TimesSquare Capital Management LLC Acquires 24,334 Shares of Encompass Health Corporation $EHC

TimesSquare Capital Management LLC lifted its holdings in Encompass Health Corporation (NYSE:EHC) by 7.2% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 362,603 shares of the company’s stock after buying an additional 24,334 shares during the period. TimesSquare Capital Management LLC owned about 0.36% of Encompass Health worth $46,058,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Aberdeen Group plc raised its holdings in Encompass Health by 0.3% during the 3rd quarter. Aberdeen Group plc now owns 351,831 shares of the company’s stock valued at $44,285,000 after buying an additional 922 shares during the period. Assetmark Inc. raised its stake in shares of Encompass Health by 88.1% in the third quarter. Assetmark Inc. now owns 299 shares of the company’s stock valued at $38,000 after acquiring an additional 140 shares during the period. Leuthold Group LLC lifted its holdings in shares of Encompass Health by 3.5% in the 3rd quarter. Leuthold Group LLC now owns 31,064 shares of the company’s stock worth $3,946,000 after acquiring an additional 1,048 shares during the last quarter. ING Groep NV purchased a new position in shares of Encompass Health during the 3rd quarter worth about $1,042,000. Finally, MQS Management LLC bought a new position in Encompass Health during the 3rd quarter valued at about $526,000. Institutional investors own 97.25% of the company’s stock.

Encompass Health Trading Down 1.8%

EHC opened at $110.02 on Friday. The company has a quick ratio of 1.14, a current ratio of 1.08 and a debt-to-equity ratio of 0.76. The stock’s fifty day moving average is $103.93 and its two-hundred day moving average is $114.54. The company has a market capitalization of $11.07 billion, a P/E ratio of 19.86, a PEG ratio of 2.10 and a beta of 0.73. Encompass Health Corporation has a 52 week low of $92.53 and a 52 week high of $127.99.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, February 5th. The company reported $1.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.29 by $0.17. The business had revenue of $3.09 billion for the quarter, compared to the consensus estimate of $1.54 billion. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.The business’s revenue was up 9.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.17 EPS. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. Barclays raised their price objective on shares of Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a research note on Friday, February 6th. Raymond James Financial upgraded Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. Finally, Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Two investment analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, Encompass Health has an average rating of “Buy” and a consensus target price of $143.29.

Insider Buying and Selling

In other news, CEO Mark J. Tarr sold 150,000 shares of the business’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $111.64, for a total value of $16,746,000.00. Following the completion of the sale, the chief executive officer owned 377,070 shares in the company, valued at approximately $42,096,094.80. The trade was a 28.46% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 2.00% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.